AI-guided heart ultrasound screening for suspected amyloidosis
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests whether an artificial-intelligence system can help decide who should get a special heart workup for a rare disease called cardiac amyloidosis. If you have signs that make doctors suspect this, the AI-guided ultrasound screening may help find it sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be identified as having a high suspicion for cardiac amyloidosis by the study’s AI screening
- You must be willing to be seen at the specialty clinic
- You must be alive to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an AI program that looks at your heart ultrasound (echocardiogram) to find possible signs of cardiac amyloidosis early. It helps doctors decide if more testing is needed.
This study uses a special heart ultrasound to look for signs of cardiac amyloidosis, a condition where abnormal proteins build up in the heart. It may help diagnose the condition earlier and guide treatment.
This study at Mayo Clinic is testing an artificial intelligence (AI) tool that analyzes echocardiograms (ultrasound of the heart) to find early signs of four types of heart muscle disease. If the AI flags a high-risk pattern, doctors can learn whether acting on that alert helps catch the condition sooner.
This study uses special heart tests (AI-ECG and CT scan) to look for a hidden condition called cardiac amyloidosis, which can affect people with atrial fibrillation. Finding it early may help guide treatment and improve outcomes.
This study looks at how cardiac amyloidosis shows up on heart imaging, especially ultrasound (echocardiography). It may help doctors better describe and track the condition using your exam and test results.
This trial tests whether using an artificial-intelligence (AI) tool during a heart ultrasound can help guide care for people at risk for heart problems. You might benefit if you have symptoms with exercise or heart risk factors, but you do not already have known heart failure or major heart disease.
Hear when a new Cardiac Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.